Literature DB >> 15231295

New concepts: growth hormone, insulin-like growth factor-I and the kidney.

Ralph Rabkin1, Franz Schaefer.   

Abstract

Both growth hormone (GH) and IGF-1 have major effects on normal kidney growth, structure and function and participate in the pathogenesis of certain kidney diseases. Furthermore when the kidneys fail there are profound changes in the circulating GH-IGF-1 system and the renal and systemic responses to these hormones. In this brief review we address the advances that have been made in our understanding of the relationship between growth hormone GH and IGF-1 and the kidney in health and the systemic and local perturbations that occur in kidney disease and identify key unanswered questions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231295     DOI: 10.1016/j.ghir.2004.02.001

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  17 in total

Review 1.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

2.  Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy.

Authors:  Jessica R Mader; Zachary T Resch; Gary R McLean; Jakob H Mikkelsen; Claus Oxvig; Ronald J Marler; Cheryl A Conover
Journal:  J Endocrinol       Date:  2013-09-06       Impact factor: 4.286

3.  Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study.

Authors:  Wei-Wen Su; King-Teh Lee; Yao-Tsung Yeh; Maw-Soan Soon; Chao-Ling Wang; Ming-Lung Yu; Shen-Nien Wang
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  A marked deficiency in circulating and renal IGF-I peptide does not inhibit compensatory renal enlargement in uninephrectomized mice.

Authors:  Daniel Landau; Jaclyn Biada; Yu Chen; Sumita Sood; Shoshanah Yakar; Derek Leroith; Yael Segev; Ralph Rabkin
Journal:  Growth Horm IGF Res       Date:  2011-08-23       Impact factor: 2.372

5.  IGF-1 and insulin exert opposite actions on ClC-K2 activity in the cortical collecting ducts.

Authors:  Oleg Zaika; Mykola Mamenko; Nabila Boukelmoune; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-22

6.  Acromegaly and end-stage renal disease: a diagnostic challenge.

Authors:  K Müssig; B Gallwitz; M B Ranke; M Horger; H U Häring; H J Quabbe
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

7.  Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.

Authors:  Daniel Landau; Renanah Eshet; Ariel Troib; Yotam Gurman; Yu Chen; Ralph Rabkin; Yael Segev
Journal:  Endocrine       Date:  2009-04-23       Impact factor: 3.633

8.  Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.

Authors:  Ya-li Kong; Yang Shen; Jun Ni; De-cui Shao; Nai-jun Miao; Jin-lan Xu; Li Zhou; Hong Xue; Wei Zhang; Xiao-xia Wang; Li-min Lu
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

Review 9.  Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age.

Authors:  Judith S Renes; Jaap van Doorn; Anita C S Hokken-Koelega
Journal:  Horm Res Paediatr       Date:  2019-09-11       Impact factor: 2.852

10.  Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line.

Authors:  Lori K Davis; Buel D Rodgers; Kevin M Kelley
Journal:  Endocrine       Date:  2008-04-08       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.